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 What ’ s known on the subject? and What does the study add? 
 ATP and acetylcholine (ACh) are released from the urothelium or from cultured 
urothelial cells in response to mechanical stretching or perturbations that mimic 
stretching, such as exposure to hypotonic solutions. Limited evidence suggests that 
ATP and ACh may interact, as the muscarinic agonist carbachol evokes ATP release 
from cultured urothelial cells. Our aim was to determine whether antimuscarinics, 
shown previously to reduce sensory nerve fi ring during bladder fi lling, might function 
by reducing mucosal ATP release. 
 By stretching mucosa strips and measuring superfusate ATP using a luciferin – luciferase 
assay, we showed that muscarinic receptor antagonism (4-DAMP, 10  nM or 
methoctramine, 1  μ M) inhibits stretching-evoked ATP release, suggesting 
anticholinergic agents used to treat human lower urinary tract pathologies act on 
urothelial muscarinic receptors. We also showed that alteration of resting mucosal 
tension is the key determinant of ATP release, as ATP is released from the mucosa in 
response to relaxation, as well to stretching. 
 OBJECTIVE 
 •  To determine whether muscarinic 
receptor antagonism affects stretching-
induced release of ATP. 
 MATERIALS AND METHODS 
 •  Mucosal strips, dissected from guinea 
pig (male, 450g;  n  = 10) urinary bladders, 
were placed in horizontal organ baths and 
superfused with Ca 2 +  -free Tyrode ’ s solution. 
 •  Superfusate samples were taken 
pre- and post- intervention (rapid 
stretching or relaxation) and ATP 
concentration was quantifi ed using a 
luciferin – luciferase assay. 
 •  The effect of muscarinic acetylcholine 
receptor antagonism on ATP release was 
assessed by addition of methoctramine 
(1  μ M) and 4-DAMP (10  nM). 
 RESULTS 
 •  Rapid stretching (0 to 13.3  ± 1.2  mN; 
no. strips  = 20) increased ATP in the 
superfusate to a median threefold increase 
over basal levels. 
 •  After a period of equilibration, tension in 
the mucosal strips relaxed until it had 
reached a new steady-state after 60  min 
and stretching was repeated. In the 
presence of 4-DAMP (10  nM) or 
methoctramine (1  μ M), ATP concentrations 
after stretching reduced to 61% or 
20%, respectively. By contrast, ATP 
concentrations in mucosa-matched 
controls, perfused with vehicle, increased 
in response to stretching by 391% and 
1500%, respectively. 
 •  Rapid relaxation also stimulated ATP 
release. This release did not appear to be 
sensitive to 4-DAMP or methoctramine. 
 CONCLUSIONS 
 •  An alteration of resting mucosal tension 
is the key determinant of ATP release, as 
ATP is released from the mucosa in 
response to both stretching and relaxation. 
 •  Muscarinic receptor antagonism inhibits 
stretching-evoked ATP release from bladder 
mucosa, suggesting that anticholinergic 
agents used to treat human lower urinary 
tract pathologies act on urothelial 
muscarinic receptors. 
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 INTRODUCTION 
 Stress-evoked release of ATP from the 
basolateral surface of the bladder wall was 
initially shown by a change in transmural 
pressure  [ 1 ] . Subsequently, ATP release has 
been measured upon lateral stretch of 
mucosal strips or urothelial cell cultures 
 [ 2 – 4 ] , as well as exposure of urothelial cells 
to hypotonic solutions to cell swelling  [ 5,6 ] . 
ATP release is greater in cells from 
overactive bladders  [ 2,3,7 ] , and reduced after 
botulinum toxin treatment  [ 8 ] . Furthermore, 
exposure to ATP itself promotes release, 
suggesting an autocatalytic process  [ 6 ] . It 
has been proposed that this ATP pool 
eventually activates adjacent afferent nerves, 
thus providing a sensory mechanism for 
relaying information about bladder volume 
 [ 9,10 ] . This hypothesis is supported by a 
reduction of afferent nerve fi ring on bladder 
fi lling in P2X3 knockout mice  [ 11 ] . A number 
of key issues remain unknown, however, 
including the processes that regulate 
stress-induced ATP release, as well as the 
cellular pathways that mediate ATP release. 
An involvement of cholinergic pathways is 
possible as acetylcholine (ACh) is also 
released from the bladder wall on stretching 
 [ 12 ] and from cultured urothelial cells 
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exposed to a hypotonic solution  [ 13 ] . 
Anticholinergic agents, used clinically to 
treat the overactive bladder, are effective in 
the fi lling phase of the micturition cycle as 
they increase bladder capacity and decrease 
sensations of urgency  [ 14,15 ] . The non-
subtype-specifi c anticholinergic oxybutynin 
and M3-specifi c anticholinergic darifenacin 
reduce afferent fi ring during bladder fi lling 
 [ 16,17 ] . This may be through direct 
desensitization of afferents, but an 
alternative hypothesis is that these drugs 
reduce the release of ATP from mucosa 
(urothelium and sub-urothelium) when the 
tissue is stressed. This hypothesis is 
supported by two lines of evidence: (1) 
muscarinic receptor activation by non-
subtype-specifi c agonists increased 
intracellular calcium and evoked ATP release 
in cultured rat urothelial cells  [ 18 ] ; and (2) 
intravesical instillation of a non-subtype-
specifi c agonist increased voiding frequency 
in an  in vivo rat preparation  [ 19 ] . To bridge 
the gap between isolated cells and whole 
animal, we measured stretching-induced 
ATP release from mucosal preparations in 
the absence and presence of two muscarinic 
receptor antagonists that have some 
selectivity for M3 or M2 subtypes. 
 MATERIALS AND METHODS 
 PREPARATION OF SAMPLES 
 Male guinea pigs (Dunkin-Hartley; approx. 
450  g) were killed by cervical dislocation 
followed by exsanguination. All experiments 
were carried out in accordance with the UK 
Animals (Scientifi c Procedures) Act 1986 and 
European Communities Council Directive 
86/09/EEC. 
 The urinary bladder was excised and placed 
in gassed (95% O 2 and 5% CO 2 ) and chilled 
(4  ° C) Tyrode ’ s solution (composition, mM: 
NaCl 114, KCl 4.7, MgSO 4 1.2, KH 2 PO 4 1.2, 
NaHCO 3 25, glucose 11.7), with no added Ca. 
The ventral wall was opened longitudinally 
and the mucosa removed by careful sharp 
dissection using iris scissors, taking care not 
to cause stretching or damage. Two strips 
(6 – 8  mm long and 2 – 3  mm wide) were cut 
along the craniocaudal axis. 
 STRETCHING OF MUCOSA STRIPS 
 Strips were tied at either end using fi ne silk 
suture (7/0; Pearsalls, Taunton, UK) and then 
transferred to a horizontal organ bath, 
where one end was tied to a fi xed hook and 
the other to the arm of an isometric tension 
transducer (FT03D; Grass Instruments, 
Quincy, MA, USA) connected to a bridge 
amplifi er (TBM-4M; WPI, Aston, UK). 
Preparations were continuously superfused 
(10  mL/min) with fresh, gassed Ca 2 +  -free 
Tyrode ’ s solution and allowed to equilibrate 
at a slack length (0  mN tension) for 1  h 
before each experiment. After equilibration, 
preparations were stretched to a constant 
tension over a period of  < 5  s by driving the 
micromanipulator arm holding the force 
transducer. Preparations equilibrated for a 
further 1  h during which time the tension 
relaxed to near pre-stretching values. The 
strips were then superfused with 4-DAMP 
(10  nM), methoctramine (1  μ M) or vehicle 
(0.1% DMSO or 0.1% water, respectively) for 
20  min, after which preparations were again 
stretched to a similar tension. After a 
further 30  min of superfusion, preparations 
were rapidly relaxed by cutting one of the 
suture ties holding the tissue. 
 SAMPLING OF SUPERFUSATE 
 Samples (100  μ L) were taken at fi xed 
timepoints during the above protocol, 
immediately before and after mechanical 
interventions (stretching, relaxation) or 
pharmacological interventions (4-DAMP, 
methoctramine or vehicle control), as well as 
at regular timepoints in between. Samples of 
superfusate were taken 0.5  cm downstream 
from the arm of the tension transducer and 
immediately frozen on dry ice for later 
assay. The length of strips was measured 
before and after the strips were stretched 
and held under tension. The mean ( SEM ; 
range) dry weight of the strips at the end of 
each experiment was 10.2 (0.7; 4.7 – 15.7) 
mg;  n s  = 20. 
 MEASUREMENT OF ATP CONCENTRATION 
USING LUCIFERIN – LUCIFERASE ASSAY 
 ATP in the superfusate was measured using 
a luciferin – luciferase assay (FL-AAM; 
Sigma-Aldrich, Poole, UK) and a 
luminometer (GloMax 20/20; Promega, 
Southampton, UK). The relationship between 
ATP concentration over the range 0.1  pM –
 100  nM and luminescence was linear on a 
log – log plot. A blank reading (without 
superfusate) was subtracted from the 
luminescence reading of each sample. There 
was no signifi cant difference in the ATP 
concentration vs luminescence relationships 
if the ATP was dissolved in distilled water or 
in gassed Ca 2 +  -free Tyrode ’ s solution. The 
ATP concentration of each sample was 
calculated relative to the standard curve and 
expressed as pmol/g dry weight of tissue. 
 STATISTICAL ANALYSIS 
 n a refers to the number of guinea pigs and 
 n s the number of mucosal strips. To 
calculate the rate of change in tension over 
time, traces were integrated, taking the 
minimum value as baseline, using Chart 
software (v.5 ADInstruments, UK). ATP data 
are presented as median (25,75% 
interquartiles), other data as mean ( SEM ). 
Differences between mean values were 
tested for statistical signifi cance using the 
Wilcoxon or Student ’ s  t -test, as appropriate; 
the null hypothesis was rejected at  P  < 0.05. 
 RESULTS 
 STRETCHING-EVOKED RELEASE OF ATP FROM 
MUCOSA STRIPS 
 The stretching protocol was validated before 
any pharmacological interventions on 
stretching-evoked ATP release were made. 
After 60  min of equilibration, unloaded 
strips (0  mN) were rapidly stretched to 
generate similar resting tensions (13.3  ± 
1.2  mN;  n s  = 20,  n a  = 10). This signifi cantly 
increased ATP concentration in the 
superfusate, from a median of 1.63  [ 0.05, 
2.40 ] to 6.60  [ 2.16, 24.74 ] pmol/g, i.e. to a 
median of 404% of basal levels ( Fig.  1A ). The 
ATP concentration was measured  ≈ 5  s after 
the stretch, as preliminary experiments 
showed that at this time the rise in ATP was 
at its maximum. To achieve the relatively 
limited range of tensions, preparations were 
stretched from a mean ( SEM ; range) initial 
length of 7.7 (0.5; 6 – 10) mm to 13.1 (1.1; 
8 – 20) mm; a mean (range) increase in 
length of 71 (22 – 122)%;  n s  = 20,  n a  = 10. 
After the initial stretching, tension in the 
mucosal strips relaxed until it had reached a 
new steady-state after 60  min. At this time 
the mean ( SEM ) tension had reduced to 1.03 
(0.23) mN and median ATP concentration 
was reduced to 2.17 (0.24, 3.8) pmol/g, i.e. 
not signifi cantly different from pre-
stretching values ( Fig.  1B ). 
 The magnitude of the increase in ATP 
concentration generated by stretching was 
not infl uenced by the initial ATP sampled at 
the unloaded (0  mN) state ( r  =  − 0.25), the 
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change in length of the strip required to 
generate tension ( r  =  − 0.14), the change of 
strip length normalized to its initial length 
( r  =  − 0.15) or the mean (range) weight of 
the animal (464  [ 422 – 489 ] g;  n a  = 10;  r  = 
0.22). The latter data were included because 
animal weight was positively associated 
with animal age. Stretching-evoked ATP 
release did not correlate with the relatively 
limited range of tension changes ( r  =  − 0.02) 
nor the integral ( r  =  − 0.02) of the change in 
tension. 
 THE EFFECT OF MUSCARINIC RECEPTOR 
ANTAGONISM ON ATP RELEASE FROM 
MUCOSA 
 The superfusate used to bathe the mucosa 
strips was changed to a solution containing 
either 4-DAMP (10  nM), methoctramine 
(1  μ M) or vehicle. The mechanical effect of 
this switch generated a transient increase 
in ATP concentration. For example, with 
superfusate containing vehicle alone, 
median ATP increased from 3.5 (3.3, 4.6) 
pmol/g to a maximum of 20.5 (18.4, 559.1) 
pmol/g after 5  min ( n s  = 5). For superfusate 
containing 4-DAMP median ATP 
concentration transiently increased from 6.3 
(2.0, 12.0) pmol/g to a maximum of 43.0 
(23.7, 147.7) pmol/g after 5  min ( n s  = 5). 
Similarly, switching to superfusate 
containing methoctramine transiently 
increased the median ATP concentration 
from 1.7 (0.05, 2.4) pmol/g to a maximum of 
6.2 (4.3, 16.9) pmol/g after 5  min ( n s  = 5). 
The magnitude of the increase (to 585%, 
682% and 373% pre-intervention, 
respectively) was similar in each case. 
After 20-min superfusion of drug or vehicle, 
ATP returned to a level not signifi cantly 
different to that before the superfusate 
change. The strips were therefore ready to 
stretch again and tension in the 
preparations was once more increased to 
previous values using the same stretching 
protocol. 
 4-DAMP VS VEHICLE 
 With mucosal strips superfused by vehicle, 
stretching increased median ATP 
concentration from 4.7 (2.1, 7.8) to 27.8 
(20.1, 34.9) pmol/g, which represents a 
median increase to 391% of basal levels ( P  < 
0.05;  n s  = 5,  n a  = 5). The percentage increase 
in ATP was similar to that at the beginning 
of the experiments and shows that the 
stretching protocol and the quantity of ATP 
release were consistent. In the presence of 
10  nM 4-DAMP, the stretching-induced 
increase in ATP was abolished and the 
concentration was actually signifi cantly 
reduced to 61% of pre-stretching levels 
( P  < 0.05;  n s  = 5,  n a  = 5;  Fig.  2 ). 
 METHOCTRAMINE VS VEHICLE 
 A similar fi nding was recorded in the 
presence of 1  μ M methoctramine. In the 
presence of vehicle alone, stretching 
increased ATP to 1750% of pre-stretching 
levels. Methoctramine abolished the 
stretching-induced increase of ATP and 
reduced ATP to 20% of control ( P  < 0.05; 
 n s  = 5,  n a  = 5;  Fig.  2 ). 
 RAPID RELAXATION AND ATP RELEASE 
 Thirty minutes after the fi nal stretching, 
in the presence or absence of an 
anticholinergic agent, the suture holding the 
mucosa strip to the force transducer arm 
was cut and tension reduced rapidly to zero. 
In all preparations there was a large increase 
in ATP concentration immediately after 
tension reduction.  Figure  3 shows the 
percentage increase in ATP concentration 
in the presence of vehicle, 4-DAMP or 
methoctramine. There was no difference in 
the percentage changes in any group. 
 RELATIONSHIP BETWEEN ATP AND 
SPONTANEOUS CONTRACTIONS OF 
MUCOSAL SHEETS 
 Mucosal sheets developed small 
spontaneous contractions that might distort 
the tissue suffi ciently to release ATP. 
 Figure  4 shows a sample experiment when 
ATP was sampled at regular intervals 
(every 60  s) and tension recorded 
simultaneously from a preparation that had 
been previously stretched to about 10  mN 
resting tension. During this time, three 
large and one smaller surges of ATP were 
recorded, but there was no strict temporal 
 FIG.  1.  A , stretching-evoked release of ATP. Guinea 
pig mucosa strips were rapidly stretched ( < 5s; 0 to 
13.3  ± 1.2  mN) and the superfusate ATP measured. 
 B , After stretching, mucosal strips relaxed to a 
steady-state tension after 60  min (left) and ATP 
concentration was measured following passive 
relaxation (right). n s  = 20, n a  = 10. 
A
100
10
1
0.1
0.01
[A
TP
], 
pm
ol
·g
−
1
P < 0.05
Uns
tret
che
d
Stre
tch
ed
30
20
10
0
Te
ns
io
n,
 m
N
[ATP], pm
ol·g
−1
100
80
60
40
20
0
P  = NS
0 60 0 60mins
Uns
tret
che
d
Stre
tch
ed
Uns
tret
che
d
Stre
tch
ed
B
 FIG.  2.  Effect of 4-DAMP or methoctramine on 
stretching-evoked ATP release. Mucosa strips were 
superfused for 20  min with 4-DAMP (10  nM) or 
methoctramine (1  μ M), rapidly stretched and ATP 
content sampled. Values are relative to superfusate 
ATP immediately before the rapid stretching 
(dashed line), i.e. in the presence of the 
intervention/vehicle. Lines connecting data points 
denote strips from the same bladder. The short 
horizontal line for each group denotes median ATP 
concentration. n s  = 20, n a  = 10. 
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correlation between ATP and the larger 
spontaneous contractions. 
 DISCUSSION 
 We showed that stretching of guinea pig 
bladder mucosa strips induced about a 
threefold release of ATP, which was 
abolished by the muscarinic receptor 
antagonists 4-DAMP and methoctramine. 
Relaxation of the strips also released ATP, to 
a far greater extent than stretching. The 
mucosa strips were sensitive to mechanical 
disturbance, as bathing with superfusate 
also evoked some release of ATP, and this 
was taken into account in our experiments. 
As a result of the present study, we made 
three important observations, each of which 
is discussed below. 
 Firstly, we showed that alteration of resting 
tension is the key determinant of ATP 
release: (i) ATP concentration increases in 
response to rapid tension and (ii) returns to 
baseline concentrations after relaxation  ≈ 1  h 
later. We chose to stretch mucosal strips to 
a consistent increase of resting tension 
rather than to a similar percentage of 
resting length  [ 4,20 ] . The large range of 
length changes (122 – 222% of original) 
required to achieve consistent tension 
changes implies that the passive mechanical 
properties of the mucosa will infl uence 
stretching-induced ATP release. Thus, there 
was no correlation between percentage 
change in strip length and the amount of 
ATP released. 
 Secondly, rapid relaxation of mucosal strips 
also stimulated signifi cant ATP release, 
suggesting that  change in tension, rather 
than the magnitude of change, is at least 
as important to evoke ATP release. 
Application of negative pressure to isolated 
detrusor myocytes increased the opening 
probability of a Gd 3 +  -sensitive ion channel, 
but there was no indication of an  ‘ off ’ 
response  [ 21 ] and thus is different from the 
observations above with the mucosal 
preparations. However, urothelium has 
a range of stretching-dependent 
mechanisms that regulate ATP release, 
including epithelial Na channels (ENaC; 
 [ 1,22,23 ] ), Gd 3 +  sensitive pathways  [ 24 ] 
and TRP channels  [ 24,25 ] . The directional 
sensitivity and relative importance of 
these different routes remain to be 
evaluated. 
 Thirdly, we showed that muscarinic receptor 
antagonists methoctramine and 4-DAMP 
inhibit stretching-induced ATP release from 
guinea pig mucosa. These experiments build 
on previous fi ndings that muscarinic 
agonists stimulate ATP release from 
urothelial cells  [ 13 ] and increase voiding 
frequency in an anaesthetized rat  [ 19 ] , to 
complete a circle in showing that 
stretching-induced release of ATP from the 
mucosa is muscarinic receptor-dependent. 
 The concentrations used were chosen to 
demonstrate a proof-of-principle for an 
effect of anticholinergic agents on ATP 
release; each agent was used at a 
concentration at least tenfold greater than 
the pK i value for the primary subtype and 
approximately equal to the pK i for the 
secondary subtype, i.e. 4-DAMP was used at 
10  nM with M3 and M2 pK i values 9.3 and 
8.1 and methoctramine was used at 1  μ M 
with M2 and M3 pK i values 7.7 and 6.0 
 [ 26,27 ] . Further experiments will be required 
to determine the subtype that exerts a more 
signifi cant effect on ATP release. 
 Of interest was the observation that in 
several experiments ATP release in the 
presence of 4-DAMP or methoctramine was 
less than baseline levels and consistent with 
an endogenous release of ACh before 
stretching was induced. This fi nding is in 
disagreement with that of Kullmann  et  al . 
 [ 19 ] in which intravesical instillation of 
atropine had no effect on voiding 
parameters in rats, suggesting inter-
preparation or inter-species differences. 
 The present data add to the evidence that 
anticholinergic agents used to treat human 
lower urinary tract pathologies act on 
mucosal muscarinic receptors and are 
consistent with the clinical observations that 
these agents act more on overactive bladder 
symptoms associated with fi lling rather than 
voiding  [ 15 ] . They also support the 
hypothesis that their action in reducing 
bladder sensations of bladder fi lling is not 
only on afferent desensitization  [ 16,17 ] , but 
also on limiting stress-induced ATP release 
itself. 
 In conclusion, M2/M3 muscarinic receptor 
antagonism inhibits stretching-evoked ATP 
release from bladder mucosa. This novel 
interaction of these drugs and ATP has 
important implications for the treatment of 
overactive bladder. 
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